Compound ID | 1869
Synonym(s): Sulopenem etzadroxil | CP-70,429 | CP-65,207
Class: Beta-lactam (penem)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins and interferes with bacterial cell wall integrity and synthesis. Less active than carbapenems against Gram-negative bacteria, no activity against Pseudomonas aeruginosa |
Description: | Synthetic compound, fixed combination with probenicid. Oral and iv formulation,not non-inferior to ertapenem in a Phase 3 clinical study in complicated intraabdominal infections and not non-inferior to ciprofloxacin in treatment of uUTI |
Institute where first reported: | Pfizer, Iterum |
Year first mentioned: | 1989 |
Highest developmental phase: | Approved by FDA in 2024 |
Development status: | Approved |
Chemical structure(s): | |||||||||||
|
|